Mitek and Verigen to market cartilage product:
This article was originally published in Clinica
German company Verigen and Mitek Worldwide, part of Johnson & Johnson subsidiary Ethicon, are to market an advanced articular cartilage repair system in the US and Canada. Mitek, which develops devices for surgical sports medicine and soft tissue repair, will carry out clinical trials and seek marketing approval. Leverkusen-based Verigen is an autologous biotherapy company specialising in tissue engineering. Its R&D efforts are concentrated on products and procedures for addressing diseases of cartilage, bone and connective tissue.